Shalby is among the largest chains of multispecialty hospitals and tertiary care centers in the country today. Currently, Shalby Hospitals ...

Shalby Ltd. key Products/Revenue Segments include Sale of services, Medicines and Other Operating Revenue for the year ending 31-Mar-2022.

“Within the hospital space, Shalby Hospitals has the largest capacity of close to 2,000 beds. Despite occupancies of less than 50%, they ha...

The SOCE centres will have highly experienced and qualified specialists equipped with the latest high-definition arthroscopic systems to de...

Shalby Ltd., incorporated in the year 2004, is a Small Cap company (having a market cap of Rs 989.91 Crore) operating in Hospitals & Allied...

Shalby has a debt free balance sheet, a unique feature among hospital chains, which are on expansion mode.

Goldman Sachs India Fund sold 1,231,536 shares of Shalby at Rs 43.04 each on BSE.

Buy Shalby Ltd. at a price target of Rs 275.

Proceeds of the IPO will be utilised towards repayment of borrowings by the company.

The issue had received 20 per cent subscription by the end of Day 1 and 46 per cent by Day 2.

Dr Shah, claims that Shalby owes him medical consultancy fees of about Rs 41 lakh.

The price band for the issue is fixed at Rs 245 to Rs 248 per equity share.

The issue had received bids for 28,93,680 shares against the total issue size of 1,45,21,686 shares.

Analysts noted that the company has delivered strong return ratios over last few years.

The hospital sector has not been rewarding for investors for the past one year.

With this, the total number of firms that have received the regulator's approval to launch initial share-sale offers in this year reached t...

Currently, the firm has a total capacity of 2,012 beds, as per Shalby's website.